SMMT icon

Summit Therapeutics
SMMT

Overview Fund Activity

97 hedge funds and large institutions have $86.3M invested in Summit Therapeutics in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 6 closing their positions.

Holders
97
Holders Change
+4
Holders Change %
+4.3%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
36
Reduced
21
Closed
6
Calls
$896K
Puts
$101K
Net Calls
+$795K
Net Calls Change
-$1.14M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$18.3M
2
Morgan Stanley
2
Morgan Stanley
New York
$3.68M
3
BlackRock
3
BlackRock
New York
$25.5M
4
State Street
4
State Street
Massachusetts
$6.41M
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$1.48M

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$0
2
SAM
2
Shell Asset Management
Netherlands
$248K
3
CL
3
CSS LLC
Illinois
$312K
4
SPIA
4
Steward Partners Investment Advisory
New York
$1.57M
5
Swiss National Bank
5
Swiss National Bank
Switzerland
$718K
Name Holding Trade Value Shares
Change 		Shares
Change %
Nisa Investment Advisors
101
Nisa Investment Advisors
Missouri
– -$168 -90 Closed
AF
102
Allworth Financial
California
– -$120 -64 Closed
1 2 3 4
5